Marie-charlotte C. Villy
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Prevalence of the Predisposing Gene MBD4 for Uveal Melanoma.
Journal: JAMA ophthalmology
Published: April 30, 2026
BARD1 and breast cancer genetic predisposition: case-control study and HRD signature analysis.
Journal: Breast cancer (Tokyo, Japan)
Published: December 05, 2025
Uveal Melanoma and the Lynch Syndrome Tumor Spectrum.
Journal: JAMA ophthalmology
Published: June 18, 2025
Methylation-sensitive high-resolution melting technology is a simple and sensitive method to detect germline epimutation of the MLH1 gene promoter.
Journal: Clinical epigenetics
Published: March 24, 2025
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers.
Journal: European journal of human genetics : EJHG
Published: February 28, 2025
High prevalence of constitutional BRCA1 epimutation in patients with early-onset triple-negative breast cancer.
Journal: Clinical epigenetics
Published: January 14, 2025
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS).
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: August 12, 2024
Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS).
Journal: Cancers
Published: January 08, 2024
Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement.
Journal: Breast (Edinburgh, Scotland)
Published: November 17, 2023
Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants.
Journal: Journal of the National Cancer Institute
Published: July 17, 2023
Last Updated: 09/26/2026